Integrating Substance Use Disorder Treatment Into Clinic-Based Internal Medicine Expands Access to Care

Why It Matters

Integrating SUD treatment into residency clinics equips future primary‑care doctors with practical skills, addressing a critical workforce gap as 48 million Americans struggle with addiction. Wider adoption could increase treatment rates and reduce barriers in the broader healthcare system.

Key Takeaways

• 73 patient visits recorded in first 15 weeks
• Resident confidence rose across diagnosis, testing, medication, counseling
• Model embeds addiction care within standard primary‑care workflow
• Potential to reduce stigma by normalizing treatment in clinics
• Other academic centers could replicate the integrated clinic model

Pulse Analysis

The United States faces a staggering 48.4 million individuals with substance‑use disorders, yet fewer than 25 percent receive treatment. Traditional medical education often relegates addiction care to theoretical lectures, leaving new physicians ill‑prepared for real‑world prescribing of buprenorphine or delivering harm‑reduction counseling. By situating SUD services inside a routine internal‑medicine residency clinic, the University of Cincinnati tackles both the supply‑side shortage of trained clinicians and the demand‑side barrier of patient stigma.

During the pilot, the clinic’s multidisciplinary team—attendings, pharmacists, addiction fellows, and residents—managed 73 visits in just 15 weeks, focusing on opioid‑ and alcohol‑use disorders. Pre‑ and post‑rotation surveys of 11 residents revealed significant gains in confidence across core competencies: diagnosing SUDs, interpreting urine drug screens, initiating medication‑assisted treatment, and providing counseling. These experiential learning moments translate into tangible skill acquisition that textbooks alone cannot deliver, positioning residents to independently manage addiction care upon graduation.

If replicated, this integrated model could reshape primary‑care curricula nationwide, creating a pipeline of physicians comfortable treating SUDs in everyday practice. Scaling the approach would require institutional commitment, reimbursement alignment, and ongoing outcome tracking to ensure patient safety and efficacy. Nonetheless, the early data suggest that embedding addiction treatment within primary‑care training not only expands access but also normalizes care, promising a modest yet meaningful shift toward closing the treatment gap for millions of Americans.